Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical & Developmental Immunology|March 26, 2011
Immune suppression in head and neck cancers: a reviewAnaëlle Duray, Stéphanie Demoulin, Pascale Hubert, et al.Anticancer Research|September 21, 2012
Detection and quantification of human papillomavirus in benign and malignant parotid lesionsGéraldine Descamps, Anaëlle Duray, Alexandra Rodriguez, et al.Oncoimmunology|July 9, 2015
Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretionStéphanie A Demoulin, Joan Somja, Anaëlle Duray, et al.Oncology Reports|April 23, 2013
Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomasAnaëlle Duray, Géraldine Descamps, Christine Decaestecker, et al.Oncology Reports|May 27, 2014
Galectin fingerprinting in naso-sinusal diseasesAnaëlle Duray, Thibault De Maesschalck, Christine Decaestecker, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|April 16, 2011
High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adultsAnaëlle Duray, Géraldine Descamps, Marie Bettonville, et al.Journal of Cancer Research and Clinical Oncology|April 9, 2010
Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinomaPerle Ernoux-Neufcoeur, Mohammad Arafa, Christine Decaestecker, et al.International Journal of Oncology|May 17, 2011
High incidence of high-risk HPV in benign and malignant lesions of the larynxAnaëlle Duray, Géraldine Descamps, Mohammad Arafa, et al.The Laryngoscope|April 26, 2012
Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinomaAnaëlle Duray, Géraldine Descamps, Christine Decaestecker, et al.Pageof 1